Dr. Melinda Beeuwkes Buntin, US Dept of Health and Human Services, discusses her papers and answers questions.
Interviews
Advertisement
The Q&A Session from the Healthcare Innovations and HIT Q&A Session at the National Press Club in Washington, DC.
Advertisement
Dr. Sachin Jain, closes the Healthcare Innovations and HIT Q&A Session at the National Press Club in Washington, DC.
Dr. A Mark Fendrick welcomes the participants to the Healthcare Innovations and HIT Q&A Session at the National Press Club.
Dr. A. Mark Fendrick explains the concept of Value-Based Insurance Design (VBID) and how it works.
Suzette Kox, MPharm, Secretary General of the International Generic and Biosimilar Medicines Association (IGBA), discusses challenges faced jointly by the US and EU biosimilars markets.
Advertisement
Gillian Woollett, MA, DPhil, senior vice president, Avalere Health, discusses how confirming "sufficient likeness" in biosimilar development can and should replace the current "totality of the evidence” approach to biosimilar development.
Advertisement
Advertisement
Trending on AJMC
1
2025 Nobel Prize in Medicine Honors Discoveries Behind Regulatory T Cells
2
FDA Expands Roflumilast Use for Atopic Dermatitis to Children Aged 2 to 5 Years
3
Aggressive Therapy Recommendations Following the STRONG-HF Trials: Stephen J. Green, MD
4
Pricing and Insurance Networks in Outpatient Surgery Markets
5
